Does image-guided radiotherapy improve toxicity profile in whole pelvic-treated high-risk prostate cancer? Comparison between IG-IMRT and IMRT.
about
Significance of image guidance to clinical outcomes for localized prostate cancerEXACTRAC x-ray and beam isocenters-what's the difference?Correlation of conventional and conformal plan parameters for predicting radiation pneumonitis in patients treated with breast cancer.RapidArc radiotherapy for whole pelvic lymph node in cervical cancer with 6 and 15 MV: a treatment planning comparison with fixed field IMRT.Gastrointestinal radiation injury: symptoms, risk factors and mechanismsGastrointestinal radiation injury: prevention and treatment.Dosimetric planning study for the prevention of anal complications after post-operative whole pelvic radiotherapy in cervical cancer patients with hemorrhoids.Measurement of eye lens dose for Varian On-Board Imaging with different cone-beam computed tomography acquisition techniques.Effect of pretreatment prostate volume on urinary quality of life following intensity-modulated radiation therapy for localized prostate cancer.Technological advances in radiation therapy for prostate cancer.Treating prostate cancer with radiotherapy.kV cone-beam CT-based IGRT: a clinical review.Offline multiple adaptive planning strategy for concurrent irradiation of the prostate and pelvic lymph nodes.A novel CBCT-based method for derivation of CTV-PTV margins for prostate and pelvic lymph nodes treated with stereotactic ablative radiotherapy.Faculty of Radiation Oncology Position Paper on the use of Image-Guided Radiation Therapy.Moderate hypofractionated radiotherapy with volumetric modulated arc therapy and simultaneous integrated boost for pelvic irradiation in prostate cancer.Transperineal implantation of gold fiducial markers (gold seeds) for prostate image-guided radiation therapy: a feasible technique associated with a low risk of complications.Fiducial marker guided prostate radiotherapy: a review.[External beam radiotherapy in the treatment of prostate cancer].Reducing rectal injury in men receiving prostate cancer radiation therapy: current perspectives.Intensity-modulated radiotherapy (IMRT) to prostate and pelvic nodes-is pelvic lymph node coverage adequate with fiducial-based image-guided radiotherapy?Whole-pelvic volumetric-modulated arc therapy for high-risk prostate cancer: treatment planning and acute toxicity.A randomized hypofractionation dose escalation trial for high risk prostate cancer patients: interim analysis of acute toxicity and quality of life in 124 patients.MRI target delineation may reduce long-term toxicity after prostate radiotherapy.Target localization and toxicity in dose-escalated prostate radiotherapy with image-guided approach using daily planar kilovoltage imaging.Image-guided, whole-pelvic, intensity-modulated radiotherapy for biochemical recurrence following radical prostatectomy in high-risk prostate cancer patients.'Compromise position' image alignment to accommodate independent motion of multiple clinical target volumes during radiotherapy: A high risk prostate cancer example.Minimal toxicity after proton beam therapy for prostate and pelvic nodal irradiation: results from the proton collaborative group REG001-09 trial.Evaluation of automated image registration algorithm for image-guided radiotherapy (IGRT).Toxicity and outcome of pelvic IMRT for node-positive prostate cancer.
P2860
Q33993238-E2FD9E69-3785-4E0E-99CC-6908C910E5ADQ34180265-EA5BFFF3-61BE-48F6-8B31-A7C7D8AC3245Q36310203-1894C6AB-2A9E-41C1-95CA-66A0DF710568Q36499999-2474605E-A015-4DE5-9CC1-3A0AB82DC1A5Q36541173-2C905B52-2545-4A5A-A16B-42981B3023BCQ36541213-EF8C6786-C370-432E-B5E8-65253F90BE7EQ37175139-83AA5ADC-C816-47A0-8819-D27097F0098AQ37248251-14D39021-9941-4904-B61B-653A0E4EE7BDQ37306267-C12B3778-25D4-4E8A-93D8-455A0C123090Q37738793-7DA42FA0-CA8F-4AFF-823C-95E109616E76Q37780448-B5AAC34F-57BC-4944-AA70-B8A7FA3FCEA1Q37870806-9B0A7510-7E57-43AA-9030-8F66E1B90245Q38392956-493A4E5C-C2FA-4291-97AA-BD375D2914E3Q38640375-D10A3036-AECB-404E-8B85-DFF9D65CF478Q38819438-CB6C5F40-5031-4420-9433-2E56AB20D655Q38921996-15B1ED17-2357-4E3C-873D-45A3C5EE8969Q38924507-F1C60A96-1C90-4269-A415-199CCFBEA5A5Q38944077-A2BA331D-49C6-47EF-B5E2-9A10FA2F7889Q39239309-096C4AD9-1FFA-4A9F-8121-59B0218C3F83Q41276603-7BEC3075-334D-4230-A3DC-F4949C470319Q41490932-8154363E-392E-4DE4-9AE4-4B5CA8F3BA3EQ41897302-977702A9-E9EC-48FA-B9D3-21BF3F168BFAQ41997352-6453CEAE-916A-4C48-9FFF-D088675D20D1Q44403736-90C8E1DE-7BDE-457E-B7F1-5F4C030F153CQ46961215-A88CD6CD-C565-4564-9378-E6E6377F314FQ48269659-7F1560AF-7F13-4721-8ECB-73C7BFBD3D26Q49011220-C2439C2F-0F9A-4D34-92F8-3BD31A5B069DQ50072796-0759537D-9E94-43FF-A9B1-9F8727A7D9CCQ51326894-DB5D2759-A681-4396-8E67-5EF895F51CCEQ53137626-6E7DF2A1-CFC8-4811-8D42-C0BBB2998EAD
P2860
Does image-guided radiotherapy improve toxicity profile in whole pelvic-treated high-risk prostate cancer? Comparison between IG-IMRT and IMRT.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Does image-guided radiotherapy ...... ison between IG-IMRT and IMRT.
@en
Does image-guided radiotherapy ...... ison between IG-IMRT and IMRT.
@nl
type
label
Does image-guided radiotherapy ...... ison between IG-IMRT and IMRT.
@en
Does image-guided radiotherapy ...... ison between IG-IMRT and IMRT.
@nl
prefLabel
Does image-guided radiotherapy ...... ison between IG-IMRT and IMRT.
@en
Does image-guided radiotherapy ...... ison between IG-IMRT and IMRT.
@nl
P2093
P1476
Does image-guided radiotherapy ...... ison between IG-IMRT and IMRT.
@en
P2093
Eileen Park-Somers
Hans T Chung
Linda W Chan
P356
10.1016/J.IJROBP.2008.03.015
P407
P50
P577
2008-05-22T00:00:00Z